| Patent Number |
Title Of Patent |
Date Issued |
| 7390627 |
Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipopro |
June 24, 2008 |
| Immunoassays for malondialdehyde-modified low density lipoprotein (MDA-modified LDL) and oxidized low density lipoprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or contro |
| 7378250 |
Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipopro |
May 27, 2008 |
| Immunoassays for malondialdehyde-modified low density lipoprotein (MDA-modified LDL) and oxidized low density lipoprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or contro |
| 6946438 |
Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for |
September 20, 2005 |
| The present invention relates to a new means for the treatment of focal ischemic cerebral infarction (ischemic stroke). It has been found that reduction of .alpha..sub.2 -antiplasmin leads to a significantly smaller focal cerebral infarct size. The invention therefore provides the use of |
| 6902733 |
Staphylokinase derivatives with polyethyleneglycol |
June 7, 2005 |
| Methods for the identification, production and use of staphylokinase derivatives characterized by a reduced immunogenicity after administration in patients. The derivatives of the invention are obtained by preparing a DNA fragment comprising at least the part of the coding sequence of |
| 6727102 |
Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipopro |
April 27, 2004 |
| Immunoassays for malondialdehyde-modified low density lipprotein (MDA-modified LDL) and oxidized low density lipprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control) |
| 6398757 |
Gene therapeutic treatment of blood vessel associated disorders |
June 4, 2002 |
| A catheter containing an inflatable balloon, which is at its periphery provided with hollow extensions that communicate between the outside of the balloon and the lumen of the catheter for use in the gene therapeutic treatment of local disorders by transfer of a desired gene to a target |
| 6383483 |
Staphylokinase derivatives with cysteine substitutions |
May 7, 2002 |
| Methods for the identification, production and use of staphylokinase derivatives characterized by a reduced immunogenicity after administration in patients. The derivatives of the invention are obtained by preparing a DNA fragment comprising at least the part of the coding sequence of |
| 5951980 |
Identification, production and use of new staphylokinase derivatives with reduced immunogenicity |
September 14, 1999 |
| Methods for the identification, production and use of derivatives of the invention obtained by preparing a DNA fragment comprising at least the part of the coding sequence of staphylokinase that provides for its biological activity; performing in vitro site-directed mutagenesis on the |
